SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-10-001863
Filing Date
2010-05-14
Accepted
2010-05-14 15:00:27
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0310_soligenix.htm 10-Q 609994
2 CERTIFICATIONS PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 f10q0310ex31i_soligenix.htm EX-31.1 16049
3 CERTIFICATIONS PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 f10q0310ex31ii_soligenix.htm EX-31.2 15566
4 CERTIFICATIONS PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 f10q0310ex32i_soligenix.htm EX-32.1 7538
5 CERTIFICATIONS PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 f10q0310ex32ii_soligenix.htm EX-32.2 6917
  Complete submission text file 0001213900-10-001863.txt   657798
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 10832729
SIC: 2834 Pharmaceutical Preparations